China Pharma (CPHI) Competitors $1.96 +0.09 (+4.59%) Closing price 10/7/2025 03:59 PM EasternExtended Trading$1.94 -0.02 (-1.28%) As of 10/7/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CPHI vs. MIRA, XCUR, ENLV, MBRX, PMN, LIXT, QTTB, RLYB, ALLR, and NNVCShould you be buying China Pharma stock or one of its competitors? The main competitors of China Pharma include MIRA Pharmaceuticals (MIRA), Exicure (XCUR), Enlivex Therapeutics (ENLV), Moleculin Biotech (MBRX), Promis Neurosciences (PMN), Lixte Biotechnology (LIXT), Q32 Bio (QTTB), Rallybio (RLYB), Allarity Therapeutics (ALLR), and NanoViricides (NNVC). These companies are all part of the "pharmaceutical products" industry. China Pharma vs. Its Competitors MIRA Pharmaceuticals Exicure Enlivex Therapeutics Moleculin Biotech Promis Neurosciences Lixte Biotechnology Q32 Bio Rallybio Allarity Therapeutics NanoViricides China Pharma (NYSE:CPHI) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership. Which has more risk & volatility, CPHI or MIRA? China Pharma has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500. Is CPHI or MIRA more profitable? MIRA Pharmaceuticals has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. China Pharma's return on equity of -63.93% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% MIRA Pharmaceuticals N/A -406.70%-328.44% Does the media prefer CPHI or MIRA? In the previous week, MIRA Pharmaceuticals had 1 more articles in the media than China Pharma. MarketBeat recorded 1 mentions for MIRA Pharmaceuticals and 0 mentions for China Pharma. China Pharma's average media sentiment score of 0.00 equaled MIRA Pharmaceuticals'average media sentiment score. Company Overall Sentiment China Pharma Neutral MIRA Pharmaceuticals Neutral Do insiders and institutionals have more ownership in CPHI or MIRA? 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 17.3% of China Pharma shares are held by company insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, CPHI or MIRA? China Pharma has higher revenue and earnings than MIRA Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$4.40M1.45-$3.08MN/AN/AMIRA PharmaceuticalsN/AN/A-$7.85M-$0.49-2.67 Do analysts recommend CPHI or MIRA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00MIRA Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryChina Pharma and MIRA Pharmaceuticals tied by winning 5 of the 10 factors compared between the two stocks. Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CPHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPHI vs. The Competition Export to ExcelMetricChina PharmaPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$6.11M$805.10M$6.11B$22.14BDividend YieldN/A4.84%5.70%3.57%P/E RatioN/A1.2585.5029.64Price / Sales1.4529.47621.4095.37Price / CashN/A17.6437.7824.65Price / Book2.807.6513.134.61Net Income-$3.08M-$7.66M$3.30B$1.01B7 Day Performance1.24%29.29%3.92%-0.14%1 Month Performance10.17%32.32%8.39%2.28%1 Year Performance-92.22%66.52%87.22%14.59% China Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPHIChina PharmaN/A$1.96+4.6%N/A-92.7%$6.11M$4.40M0.00250MIRAMIRA Pharmaceuticals0.5403 of 5 stars$1.36+2.3%N/A+17.0%$25.36MN/A-2.782XCURExicure1.7302 of 5 stars$4.09+4.9%N/A+52.8%$24.64M$500K-1.0550Positive NewsENLVEnlivex Therapeutics2.1948 of 5 stars$1.04+3.0%$10.00+861.5%-26.1%$24.54MN/A-1.7970MBRXMoleculin Biotech3.0133 of 5 stars$0.53+8.9%$4.00+654.7%-80.7%$24.10MN/A0.0020Gap UpPMNPromis Neurosciences3.1215 of 5 stars$0.43-3.4%$4.33+919.6%-50.8%$23.68MN/A-2.025News CoverageGap UpLIXTLixte Biotechnology0.2931 of 5 stars$5.03-3.1%N/A+173.1%$23.67MN/A-3.904Negative NewsQTTBQ32 Bio2.9213 of 5 stars$1.98+2.1%$12.17+514.5%-94.2%$23.66M$1.16M-0.4639RLYBRallybio3.1935 of 5 stars$0.50-10.4%$5.00+902.0%-50.4%$23.27M$640K-0.5340Short Interest ↓Gap DownHigh Trading VolumeALLRAllarity Therapeutics2.6684 of 5 stars$1.58-0.6%$9.25+485.4%+6.7%$23.09MN/A0.0010NNVCNanoViricides0.2806 of 5 stars$1.43+0.7%N/A+3.3%$22.98MN/A-1.9920 Related Companies and Tools Related Companies MIRA Pharmaceuticals Competitors Exicure Competitors Enlivex Therapeutics Competitors Moleculin Biotech Competitors Promis Neurosciences Competitors Lixte Biotechnology Competitors Q32 Bio Competitors Rallybio Competitors Allarity Therapeutics Competitors NanoViricides Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CPHI) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
